Doctor profile · Federal record
Dr. Nusayba Bagegni, MD
Medical Oncology Physician (CMS: Medical Oncology) · Saint Louis, MO
- NPI 1760795660
- Accepts Medicare
- MIPS 79.3 / 100 · 2023
- 16 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
4921 Parkview Pl, Div Im Medical Oncology, Ste 7A, 7B, 7C
Saint Louis, MO 631101032
(800) 647-2098
fax (314) 362-3192 - Mailing address
-
Po Box 7412011
Chicago, IL 606742011
Credentials & registration
- NPI registered
- July 2010 — 16 yrs on file
- Profile last updated
- April 15, 2025
- Year of graduation
- 2010 — 16 yrs since
- Specialty taxonomy
- 207RX0202X — NUCC code
- State license (1)
- Missouri #2013020285
- Medicaid
- MO #200005958
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1760795660. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
9,788
Distinct HCPCS
10
Medicare allowed
$198,916
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1453 |
Injection, fosaprepitant, 1 mg | 2,700 | 12 | $0 | |
J0897 |
Injection, denosumab, 1 mg | 2,520 | 14 | $23 | |
Q5119 |
Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 1,360 | 11 | $29 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 870 | 41 | $0 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 510 | 29 | $1 | |
J2506 |
Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 312 | 14 | $97 | |
J1626 |
Injection, granisetron hydrochloride, 100 mcg | 190 | 12 | $0 | |
96375 |
Injection of additional new drug or substance into vein | 160 | 49 | $15 | |
36415 |
Insertion of needle into vein for collection of blood sample | 147 | 71 | $8 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 141 | 67 | $127 |
In context: peer comparison
Among 44 peers in Saint Louis Medical Oncology Physician, average services per provider: 919. This provider delivers 11× the peer median.Medicare Part D · 2023
Top prescriptions
Total claims
1,037
Patients
233
Total drug cost
$2,390,595
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 318 | 83 | $11,442 |
| Letrozole | Generic | 145 | 37 | $5,532 |
| Ibrance (Palbociclib) | Brand | 112 | 13 | $1,901,561 |
| Tamoxifen Citrate | Generic | 81 | 26 | $2,632 |
| Gabapentin | Generic | 59 | 0 | $602 |
| Exemestane | Generic | 57 | 14 | $10,861 |
| Prednisone | Generic | 41 | 0 | $316 |
| Eliquis (Apixaban) | Brand | 39 | 0 | $34,143 |
| Prochlorperazine Maleate | Generic | 38 | 19 | $1,207 |
| Dexamethasone | Generic | 33 | 20 | $539 |
Hospital affiliations
Frequently asked questions
What is Dr. Nusayba Bagegni's medical specialty?
Dr. Nusayba Bagegni practices Medical Oncology Physician in Saint Louis, MO.
Where does Dr. Nusayba Bagegni practice?
Dr. Nusayba Bagegni practices at 4921 Parkview Pl, Saint Louis, MO 631101032. Office phone: 8006472098.
What is Dr. Nusayba Bagegni's NPI?
Dr. Nusayba Bagegni's National Provider Identifier (NPI) is 1760795660, issued by NPPES.
Does Dr. Nusayba Bagegni accept Medicare assignment?
Yes. Dr. Nusayba Bagegni accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Nusayba Bagegni commonly perform?
Top Medicare-reported procedures in 2023: Injection, fosaprepitant, 1 mg (HCPCS J1453); Injection, denosumab, 1 mg (HCPCS J0897); Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg (HCPCS Q5119). Source: CMS Medicare Physician & Other Practitioners file.